I have been reading the Hepatitis SA Community News for a long time, perhaps since its inception! I have always been interested to read other people’s stories of living with hep C. The time has come for me to tell my tale.
I have been living with the hep C virus for over 30 years, contracting it some time in the mid-to-late ‘80s. In my late teens and early twenties I discovered that injecting various drugs was a wonderful form of escape. My need to obliterate myself during this period was the result of having been sexually abused in my early teens by the leader of a NSW Church of England Boys Society group.
Continue reading “When treatment, and everything else, goes wrong: David’s story”
In this final instalment of conversations with Hepatitis SA peer educators, Margie, Penni, Justin and Sue reflect on the rewards they find in the job. Read previous instalments: Part 1 | Part 2
Continue reading “Five Years of CNP Peers: Part 3”
Second instalment of conversations with Hepatitis SA CNP peer educators—Bernadette and Justin talk about what motivated them to become educators to their peers. Read Part 1 here.
Continue reading “Five Years of CNP Peers: Part 2”
Among its other services, Hepatitis SA runs four Clean Needle Program (CNP) sites in Adelaide, at Hackney, Noarlunga, Port Adelaide, and Salisbury. Our CNP peer educators also attend rostered sessions at other sites at various times during the week.
Continue reading “Five Years of CNP Peers: Part 1”
Most accidental overdoses in Australia—especially South Australia—are from prescription drugs, mainly painkillers and sleeping tablets. Many of these deaths can be prevented with a drug that reverses the effects of opioids.
From 1 December 2019 to February 2021, South Australia is taking part in a PBS-subsidised pilot program to reduce opioid-related deaths by making the life-saving medicine, naloxone, available to more people.
Continue reading “Keep Calm and Carry Naloxone”
Competing priorities for people who inject drugs
Opioid substitution treatment (OST) clinics are considered ideal locations for providing treatment for people with chronic hepatitis C virus infection who inject drugs, a vital priority group for achieving the goal of HCV elimination. But despite the availability of highly effective treatments with relatively few side effects, treatment uptake is yet to reach the level needed to achieve elimination.
Continue reading ““I’ll have hep C treatment eventually.””